Key result
FOXO1 inhibition mitigates chronic hypoxic cardiomyocyte injury in Tetralogy of Fallot by maintaining mitochondrial quality control via the AMPK/FOXO1/ROCK1 pathway.
Why the study?
Persistent chronic hypoxia causes disturbances in mitochondrial quality control and cardiomyocyte injury in Tetralogy of Fallot, but the key effector molecules remained to be identified.
Inhibition of the FOXO1-ROCK1 axis or administration of miR-27b-3p may offer a therapeutic strategy to protect against chronic hypoxic cardiomyocyte injury in Tetralogy of Fallot.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for FOXO1-ROCK1 targeting in hypoxic cardiomyocyte injury; clinical translation in Tetralogy of Fallot remains untested.
Persistent chronic myocardial hypoxia causes disturbances in mitochondrial quality control (MQC), ultimately leading to increased cardiomyocyte injury in patients with Tetralogy of Fallot (TOF). The present study aimed to identify the key effector molecules of cardiomyocyte injury under chronic hypoxia in TOF. Clinical data from TOF patients were collected and whole transcriptome sequencing was performed on myocardial samples. Chronic hypoxia models were established in cardiac-specific knockout mice and cardiomyocytes, and a series of molecular experiments were used to determine the specific mechanisms involved. Clinical cohort data and whole-transcriptome sequencing analysis of myocardial samples from TOF patients revealed that forkhead box O1 (FOXO1) plays an important role in chronic hypoxic cardiomyocyte injury. In a model of chronic hypoxia established in FOXO1 cardiac-specific knockout mice and FOXO1 gene-deficient cardiomyocytes, the AMPK signaling pathway regulates the expression of FOXO1, which in turn disrupts MQC by regulating the transcriptional activation of Rho-associated protein kinase 1 (ROCK1), and increasing the production of mitochondrial ROS, thereby exacerbating damage to cardiomyocytes. Excessive reactive oxygen species (ROS) production during MQC dysfunction further activates Cox7a2L to increase the assembly of the respiratory chain supercomplex. In addition, we found that miR-27b-3p partially binds to the 3′ untranslated region of FOXO1 to exert a protective effect. Maintenance of MQC under chronic hypoxia is achieved through a series of injury-protection mechanisms, suggesting that FOXO1 inhibition may be crucial for future mitigation of chronic hypoxic cardiomyocyte injury in TOF. • Clinical data on patients with TOF found that the severity of hypoxia plays a key role in prognosis. • Explore therapeutic targets for TOF myocardial protection using whole transcriptome sequencing of myocardial samples. • Elucidate the specific mechanism of cardiomyocyte injury by FOXO1-ROCK1 axis-mediated MQC disorders. • miR-27b-3p can attenuate myocardial chronic hypoxic injury by partially binding to the 3'UTR of FOXO1. • ROS-induced Cox7a2L activation upregulates respiratory chain supercomplex function for cardiomyocyte protection.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2024) studied Tetralogy of Fallot. FOXO1 inhibition was evaluated on cardiomyocyte injury. FOXO1 inhibition mitigates chronic hypoxic cardiomyocyte injury in Tetralogy of Fallot by maintaining mitochondrial quality control via the AMPK/FOXO1/ROCK1 pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: